Replies to post #340529 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

My error. Yes, thank you; later, 2023 for the Alzheimer's results. Will take some time after that (months? years?) for the FDA to act.

But Rett results are forthcoming. They will adequately substantiate the unique mechanism of action (MOA), acting propitiously against a CNS disease. Rett results will portend the same for Parkinson's disease dementia and Alzheimer's. Blarcamesine efficacy and safety data will no longer be based on lab rat results. It will be the drug acting favorably in real humans with a real, otherwise recalcitrant central nervous system disease. Anavex and blarcamesine "maybe's" will become "very likely's."

The "market," in its great wisdom, will respond. A few market players, even, might recall seeing the numbers I just posted --- or, will punch their own.